AKT1 and metabolic dysfunction-associated steatotic liver disease: Expression of TREM1 is upregulated, and overexpression of TREM1 increases lipid accumulation-related genes via the PI3K/AKT signaling pathway in non-alcoholic fatty liver disease (NAFLD) [87].